A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

A new report examines whether Iowa farmers, highly exposed to pesticides, are getting cancer more often than others in the ...

For the first time in 30 years, there is a new FDA-approved treatment for locally advanced pancreatic cancer. Frederick Health is the first in the U.S. to bring this advancement to patients. It’s ...

For the first time in 30 years, there is a new FDA-approved treatment for locally advanced pancreatic cancer.

Encouraging preclinical and translational data supporting DNase-based approaches to target NETs in difficult-to-treat cancers ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors.

Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced ...

NEW YORK – Cbio will begin a European Phase I/II trial of its autologous T-cell therapy novoleucel for patients with late-stage cervical cancer, with initial results expected by the end of the year.

Cancer cachexia impacts almost 90% of people living with pancreatic cancer. Learn more about this condition in this Q&A with Nicolas Clifford, PanCAN’s manager of research and education communication.

Until now, the following has been true for metastatic pancreatic cancer: Once the tumor has spread, local treatment such as surgery is usually no longer an option.

The disease entered Linda Adhiambo’s family in 2007 and never left. It has taken her mother, grandmother, aunt and cousins. Now, as she battles breast cancer, she asks: when will this cycle end?